BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 36
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (15923)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.
Item 
Count 
PDF1031
WORD385
HTML11215
Figures (1-2)397
Tables (1-1)218
 Sum=13246
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1399
Download1278
 Sum=2677
Sep 28, 2014 (publication date) through Jan 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: What the clinician needs to know. World J Gastroenterol 2014; 20(36): 12956-12980 [PMID: 25278691 DOI: 10.3748/wjg.v20.i36.12956]
URL: https://www.wjgnet.com/1007-9327/full/v20/i36/12956.htm
Number Citing Articles
1
Qiming Li, Yong Han, Haofei Hu, Yuzheng Zhuge. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with non-alcoholic fatty liver disease: A secondary prospective cohort study in non-obese Chinese adults. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.995749
2
Aybike Birerdinc, Zobair Younossi. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?. Journal of Hepatology 2015; 62(4): 761 doi: 10.1016/j.jhep.2015.01.005
3
Andreea-Manuela Mirea, Erik J. M. Toonen, Inge van den Munckhof, Isabelle D. Munsterman, Eric T. T. L. Tjwa, Martin Jaeger, Marije Oosting, Kiki Schraa, Joost H. W. Rutten, Marinette van der Graaf, Niels P. Riksen, Jacqueline de Graaf, Mihai G. Netea, Cees J. Tack, Triantafyllos Chavakis, Leo A. B. Joosten. Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. Molecular Medicine 2019; 25(1) doi: 10.1186/s10020-019-0084-3
4
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?. Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
5
Yahui Ding, Zhiyang Zhang, Zhongbao Yue, Liugang Ding, Yong Zhou, Zebo Huang, Hongliang Huang. Rosmarinic Acid Ameliorates H2O2-Induced Oxidative Stress in L02 Cells Through MAPK and Nrf2 Pathways. Rejuvenation Research 2019; 22(4): 289 doi: 10.1089/rej.2018.2107
6
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
7
Łukasz Blukacz, Artur Nowak, Mariusz Wójtowicz, Angelika Krawczyk, Grzegorz Franik, Paweł Madej, Dagmara Pluta, Karolina Kowalczyk, Michał Żorniak. Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines 2022; 10(9): 2193 doi: 10.3390/biomedicines10092193
8
Mohammad Reza Amini, Fatemeh Sheikhhossein, Alireza Talebyan, Elham Bazshahi, Farhang Djafari, Azita Hekmatdoost. Effects of Artichoke Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical Nutrition Research 2022; 11(3): 228 doi: 10.7762/cnr.2022.11.3.228
9
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00010
10
Siyu Ren, Jianyu Wang, Zhanchen Dong, Jixun Li, Yu Ma, Ying Yang, Tian Zhou, Tianming Qiu, Liping Jiang, Qiujuan Li, Xiance Sun, Xiaofeng Yao. Perfluorooctane sulfonate induces ferroptosis-dependent non-alcoholic steatohepatitis via autophagy-MCU-caused mitochondrial calcium overload and MCU-ACSL4 interaction. Ecotoxicology and Environmental Safety 2024; 280: 116553 doi: 10.1016/j.ecoenv.2024.116553
11
Ruijie Gong, Xiaofei Lv, Fengqiong Liu. MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1. Cellular & Molecular Biology Letters 2018; 23(1) doi: 10.1186/s11658-018-0083-3
12
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy. Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Metabolites 2020; 10(7): 283 doi: 10.3390/metabo10070283
13
Xianhui Qin, Youbao Li, Hui Yuan, Di Xie, Genfu Tang, Binyan Wang, Xiaobin Wang, Xin Xu, Xiping Xu, Fanfan Hou. Relationship of MTHFR Gene 677C→T Polymorphism, Homocysteine, and Estimated Glomerular Filtration Rate Levels With the Risk of New-Onset Diabetes. Medicine 2015; 94(7): e563 doi: 10.1097/MD.0000000000000563
14
LORENA CASTRO S., GUILLERMO SILVA P.. HÍGADO GRASO NO ALCOHÓLICO. Revista Médica Clínica Las Condes 2015; 26(5): 600 doi: 10.1016/j.rmclc.2015.09.006
15
Jielei Zhang, Nengguang Fan, Yongde Peng. Heat shock protein 70 promotes lipogenesis in HepG2 cells. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0722-8
16
Giordano Sigon, Roberta D'Ambrosio, Mariagrazia Clerici, Giuseppina Pisano, Veena Chantarangkul, Roberta Sollazzi, Rosa Lombardi, Flora Peyvandi, Pietro Lampertico, Silvia Fargion, Armando Tripodi, Anna Ludovica Fracanzani. Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis. Liver International 2019; 39(12): 2309 doi: 10.1111/liv.14213
17
Cristiane Fonseca de Almeida, Paula Simplicio da Silva, Claudia Santos de Aguiar Cardoso, Nathalia Gorni Moreira, Julliana Cormack Antunes, Michelle Morata de Andrade, Julio Silva, Marina Campos Araujo, Wilza Arantes Ferreira Peres, Pedro Emmanuel Alvarenga Americano do Brasil, Ronaldo Ismerio Moreira, Sandra W. Cardoso, Valdilea G. Veloso, Beatriz Grinsztejn, Patricia Dias de Brito, Hugo Perazzo. Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV. Nutrients 2021; 13(10): 3462 doi: 10.3390/nu13103462
18
Silke Crommen, Karl Peter Rheinwalt, Andreas Plamper, Marie-Christine Simon, Daniela Rösler, Rolf Fimmers, Sarah Egert, Christine Metzner. A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease—Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery. The Journal of Nutrition 2022; 152(2): 408 doi: 10.1093/jn/nxab392
19
Hong-Gi Kim, Jin-Ho Park, Ha-Hyun Shin, So-Hee Kim, Ha-Eun Jeon, Ji-Hwa Shin, Young-Suk Won, Hyo-Jung Kwon, Eun-Seok Jeon, Byung-Kwan Lim. Liver-specific Coxsackievirus and adenovirus receptor deletion develop metabolic dysfunction–associated fatty liver disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72561-2
20
Laura Ioana Mazilescu, Markus Selzner, Nazia Selzner. Defatting strategies in the current era of liver steatosis. JHEP Reports 2021; 3(3): 100265 doi: 10.1016/j.jhepr.2021.100265
21
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
22
Min-Sun Kwak, Donghee Kim. Long-Term Outcomes of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2015; 14(2): 69 doi: 10.1007/s11901-015-0258-6
23
Sandra Steensels, Jixuan Qiao, Yanzhen Zhang, Kristal M. Maner‐Smith, Nourhan Kika, Corey D. Holman, Kathleen E. Corey, W. Clay Bracken, Eric A. Ortlund, Baran A. Ersoy. Acyl‐Coenzyme A Thioesterase 9 Traffics Mitochondrial Short‐Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver. Hepatology 2020; 72(3): 857 doi: 10.1002/hep.31409
24
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. Clínica e Investigación en Arteriosclerosis 2021; 33(5): 257 doi: 10.1016/j.arteri.2020.12.007
25
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. World Journal of Gastroenterology 2016; 22(44): 9706-9717 doi: 10.3748/wjg.v22.i44.9706
26
Jie Yu, Xuesong Yang, Xuefeng Yang, Mengxue Yang, Pan Wang, Yu Yang, Jing Yang, Wenmei Li, Jie Xu. Nonylphenol aggravates non-alcoholic fatty liver disease in high sucrose-high fat diet-treated rats. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21725-y
27
Liya Chen, Yao Wang, Weikun Zheng, Hu Zhang, Yan Sun, Yiping Chen, Qi Liu. Improvement of obesity-induced fatty liver disease by intermittent hypoxia exposure in a murine model. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1097641
28
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
29
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
30
Do Hoon Kim, Yu Hwa Park, Jung Suk Lee, Hyun Il Jeong, Kye Wan Lee, Tong Ho Kang. Anti-Obesity Effect of DKB-117 through the Inhibition of Pancreatic Lipase and α-Amylase Activity. Nutrients 2020; 12(10): 3053 doi: 10.3390/nu12103053
31
Mariana Verdelho Machado, Anna Mae Diehl. Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology 2016; 150(8): 1769 doi: 10.1053/j.gastro.2016.02.066
32
Eyal Shteyer, Rivka Villenchik, Mahmud Mahamid, Nidaa Nator, Rifaat Safadi. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease. International Journal of Molecular Sciences 2016; 17(3): 312 doi: 10.3390/ijms17030312
33
Yu Feng, Yan Chen, Binrui Yang, Qingping Lan, Tao Wang, Guozhen Cui, Zhitao Ren, I. Cheong Choi, George Pak-Heng Leung, Fenggen Yan, Dacan Chen, Hon Ho Yu, Simon Ming Yuen Lee. Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7465272
34
Shih-Wei Lai. Smoking and Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology 2019; 114(6): 998 doi: 10.14309/ajg.0000000000000204
35
Silvia Ferolla, Cláudia Couto, Luciana Costa-Silva, Geyza Armiliato, Cristiano Pereira, Flaviano Martins, Maria Ferrari, Eduardo Vilela, Henrique Torres, Aloísio Cunha, Teresa Ferrari. Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients 2016; 8(7): 397 doi: 10.3390/nu8070397
36
Lihua Song, Xin Gang Zhao, Peng Ling Ouyang, Qi Guan, Li Yang, Fengju Peng, Huanwang Du, Fei Yin, Wei Yan, Wen Juan Yu, Hongli Yan. Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial. British Journal of Nutrition 2020; 123(10): 1148 doi: 10.1017/S0007114520000495
37
Aki J. Käräjämäki, Olli-Pekka Pätsi, Markku Savolainen, Y. Antero Kesäniemi, Heikki Huikuri, Olavi Ukkola, Giovanni Targher. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). PLOS ONE 2015; 10(11): e0142937 doi: 10.1371/journal.pone.0142937
38
Xiangjin Meng, Xin Guo, Jing Zhang, Junji Moriya, Junji Kobayashi, Reimon Yamaguchi, Sohsuke Yamada. Acupuncture on ST36, CV4 and KI1 Suppresses the Progression of Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Metabolites 2019; 9(12): 299 doi: 10.3390/metabo9120299
39
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera, Dimitri P Mikhailidis. Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review. Current Vascular Pharmacology 2024; 22(3): 187 doi: 10.2174/0115701611285401240110074530
40
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2): 53 doi: 10.1159/000504602
41
Mariana Verdelho Machado, Gregory Alexander Michelotti, Guanhua Xie, Thiago Pereira de Almeida, Jerome Boursier, Brittany Bohnic, Cynthia D. Guy, Anna Mae Diehl, Silvia C. Sookoian. Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease. PLOS ONE 2015; 10(5): e0127991 doi: 10.1371/journal.pone.0127991
42
Juan-Fen Mo, Jia-Yuan Wu, Li Zheng, Ya-Wei Yu, Tian-Xin Zhang, Li Guo, Yi Bao. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice. RSC Advances 2018; 8(54): 31194 doi: 10.1039/C8RA05915B
43
Yvonne Alt, Jörn M. Schattenberg. Derzeit bleiben als Gegenmittel nur Aufmerksamkeit und Lebensstilmodifikation. Info Diabetologie 2015; 9(1): 28 doi: 10.1007/s15034-014-0624-4
44
Vajiheh Rangboo, Mostafa Noroozi, Roza Zavoshy, Seyed Amirmansoor Rezadoost, Asghar Mohammadpoorasl. The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis. International Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/4030476
45
Elina Manzhalii, Oleksandr Virchenko, Tetyana Falalyeyeva, Tetyana Beregova, Wolfgang Stremmel. Treatment efficacy of a probiotic preparation for non‐alcoholic steatohepatitis: A pilot trial. Journal of Digestive Diseases 2017; 18(12): 698 doi: 10.1111/1751-2980.12561
46
Hiroki Kanamori, Yohei Yamada, Yoko Ito, Koji Shirosaki, Satoko Yamagishi, Yutaro Maeda, Yumi Kudo, Tomoshige Umeyama, Nobuhiro Takahashi, Mototoshi Kato, Yasushi Hasegawa, Kentaro Matsubara, Masahiro Shinoda, Hideaki Obara, Rie Irie, Hanako Tsujikawa, Hajime Okita, Phuong Thanh Nguyen, Kenichi Saigo, Shigeki Mitsunaga, Ituro Inoue, Yuko Kitagawa, Tatsuo Kuroda. Noninvasive graft monitoring using donor‐derived cell‐free DNA in Japanese liver transplantation. Hepatology Research 2024; 54(3): 300 doi: 10.1111/hepr.13978
47
Inhye Kim, Mi-lang Kyun, Hyewon Jung, Ji-In Kwon, Jeongha Kim, Ju-Kang Kim, Yu Bin Lee, Young-In Kwon, Kyoung-Sik Moon. In Vitro Nonalcoholic Fatty Liver Disease Model Elucidating the Effect of Immune Environment on Disease Progression and Alleviation. ACS Omega 2024; 9(23): 25094 doi: 10.1021/acsomega.4c02433
48
Jinyu Li, Lijia Yin, Siyi Chen, Zelin Li, Jiatong Ding, Jiaqiang Wu, Kangping Yang, Jixiong Xu. The perspectives of NETosis on the progression of obesity and obesity-related diseases: mechanisms and applications. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1221361
49
Pooja Yadav, Khushi Quadri, Renu Kadian, Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam. New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products. iLIVER 2024; 3(4): 100131 doi: 10.1016/j.iliver.2024.100131
50
Juan Caballeria, Llorenç Caballeria. Hígado graso no alcohólico. Papel de los médicos de atención primaria. Medicina Clínica 2015; 145(3): 112 doi: 10.1016/j.medcli.2015.04.012
51
Nikhil Gupta, Waseem Ramzaan Dar, Asma Wani, Rachit Raj Saxena, Sahil Khatri, Bhumesh Tyagi, Pankaj Bansal, Irfan Ahmad Mir. Comparison of aspartate aminotransferase platelet ratio index score and insulin resistance in type 2 diabetes mellitus with non-alcoholic fatty liver disease. Endocrine Regulations 2023; 57(1): 106 doi: 10.2478/enr-2023-0013
52
Eun Mi Ahn. Effects of Ethanol Extracts from Commonly Consumed Vegetables in Korea on Differentiation and Secretion of MCP-1 and Adiponectin in 3T3-L1 Adipocytes and Lipid Accumulation in HepG2 Hepatocytes. Journal of the East Asian Society of Dietary Life 2015; 25(1): 99 doi: 10.17495/easdl.2015.2.25.1.99
53
Mina AkbariRad, Masoud Pezeshki Rad, Hadi Nobakht, AmirAli Moodi Ghalibaf, Abdollah Firoozi, Ashkan Torshizian, Amir Reza Bina, Ali Beheshti Namdar, Masoumeh Sadeghi. Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03302-y
54
Maria Luz Fernandez. Lifestyle Factors and Genetic Variants Associated to Health Disparities in the Hispanic Population. Nutrients 2021; 13(7): 2189 doi: 10.3390/nu13072189
55
Wen Cao, Xing An, Longfei Cong, Chaoyang Lyu, Qian Zhou, Ruijun Guo. Application of Deep Learning in Quantitative Analysis of 2‐Dimensional Ultrasound Imaging of Nonalcoholic Fatty Liver Disease. Journal of Ultrasound in Medicine 2020; 39(1): 51 doi: 10.1002/jum.15070
56
Sulan Lin, Yajing Xian, Yi Liu, Wen Cai, Jiangmei Song, Xiangyang Zhang. Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China. Medicine 2018; 97(9): e0021 doi: 10.1097/MD.0000000000010021
57
Mariana Verdelho Machado, Anna Mae Diehl. The hedgehog pathway in nonalcoholic fatty liver disease. Critical Reviews in Biochemistry and Molecular Biology 2018; 53(3): 264 doi: 10.1080/10409238.2018.1448752
58
Nuria Perez-Diaz-del-Campo, Itziar Abete, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease. Nutrients 2020; 12(5): 1260 doi: 10.3390/nu12051260
59
Stephania Guzman, Magdalena Dragan, Hyokjoon Kwon, Vanessa de Oliveira, Shivani Rao, Vrushank Bhatt, Katarzyna M. Kalemba, Ankit Shah, Vinod K. Rustgi, He Wang, Paul R. Bech, Ali Abbara, Chioma Izzi-Engbeaya, Pinelopi Manousou, Jessie Y. Guo, Grace L. Guo, Sally Radovick, Waljit S. Dhillo, Fredric E. Wondisford, Andy V. Babwah, Moshmi Bhattacharya. Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model. Journal of Clinical Investigation 2022; 132(10) doi: 10.1172/JCI145889
60
Xia-Xia Zhao, Rui-Ling Wang, Ming-Hao Liu, Xiao-jun Huang, Chiara Ricci. Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6696473
61
Niki S. Kakouri, Costas G. Thomopoulos, Eirini P. Siafi, Angeliki E. Valatsou, Kyriakos S. Dimitriadis, Iliana P. Mani, Sotirios P. Patsilinakos, Dimitrios M. Tousoulis, Konstantinos P. Tsioufis. Overview of the Association between Non-Alcoholic Fatty Liver Disease and Hypertension. Cardiology Discovery 2023;  doi: 10.1097/CD9.0000000000000113
62
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
63
Ahmed Abdel-Razik, Nasser Mousa, Walaa Shabana, Mohamed Refaey, Rasha Elzehery, Rania Elhelaly, Khaled Zalata, Mostafa Abdelsalam, Ahmed A. Eldeeb, Mahmoud Awad, Ayman Elgamal, Ahmed Attia, Niveen El-Wakeel, Waleed Eldars. Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1237 doi: 10.1097/MEG.0000000000001232
64
E. Roeb, M. Roderfeld. Mikrobiom zwischen Intestinum und Leber. Der Gastroenterologe 2015; 10(2): 111 doi: 10.1007/s11377-014-0961-9
65
Mariana Verdelho Machado, Gregory Alexander Michelotti, Thiago Almeida Pereira, Guanhua Xie, Richard Premont, Helena Cortez-Pinto, Anna Mae Diehl. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. Journal of Hepatology 2015; 63(4): 962 doi: 10.1016/j.jhep.2015.05.031
66
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele, Giovanni Targher. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 2015; 47(12): 997 doi: 10.1016/j.dld.2015.08.004
67
Hua Cai, Yue-Lan Qin, Ze-Ya Shi, Jin-Hui Chen, Min-Jie Zeng, Wei Zhou, Ru-Qun Chen, Zhi-Yuan Chen. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1132-8
68
Biyu Hou, Yuerong Zhao, Guifen Qiang, Xiuying Yang, Chunyang Xu, Xi Chen, Chenge Liu, Xiaobo Wang, Li Zhang, Guanhua Du, Giuseppe Valacchi. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF‐β Signaling Pathway Activation in Type 2 Diabetic Rats. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/4545321
69
Mariana Verdelho Machado. Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3627 doi: 10.2147/DMSO.S304357
70
Ying Yang, Xiaojing Wang. Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1419384
71
Yeon Ji Chae, Dae Won Jun, Waqar Khalid Saeed, Hyeon Tae Kang, Ju Hee Oh, Seung Min Lee, Kiseok Jang. Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies. Journal of Korean Medical Science 2019; 34(2) doi: 10.3346/jkms.2019.34.e14
72
Evaluation of hepcidin and its relationship with iron in non-alcoholic fatty liver disease. Biomedicine 2022; 42(1): 173 doi: 10.51248/.v42i1.680
73
Emma T. Saltzman, Talia Palacios, Michael Thomsen, Luis Vitetta. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00061
74
Panyisha Wu, Moya Zhang, Nicholas J. G. Webster. Alternative RNA Splicing in Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.613213
75
Ramiar Kheder, James Hobkirk, Zeayd Saeed, Justyna Janus, Sean Carroll, Michael J. Browning, Cordula Stover. Vitamin D3supplementation of a high fat high sugar diet ameliorates prediabetic phenotype in female LDLR−/−and LDLR+/+mice. Immunity, Inflammation and Disease 2017; 5(2): 151 doi: 10.1002/iid3.154
76
Sou Hyun Kim, Yong Lim, Ju Bin Park, Jae-Hwan Kwak, Keuk-Jun Kim, Joung-Hee Kim, HyunKeun Song, Joon Young Cho, Dae Youn Hwang, Kil Soo Kim, Young-Suk Jung. Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources. Laboratory Animal Research 2017; 33(2): 157 doi: 10.5625/lar.2017.33.2.157
77
Bradley J. McEwen. Can methylenetetrahydrofolate reductase (MTHFR) polymorphisms increase the risk of chronic disease, such as non-alcoholic fatty liver disease (NAFLD)?. Advances in Integrative Medicine 2016; 3(3): 109 doi: 10.1016/j.aimed.2017.03.001
78
Ethan C. Z. Lee, Vickram V. Anand, Alex C. Razavi, Pamela L. Alebna, Mark D. Muthiah, Mohammad S. Siddiqui, Nicholas W. S. Chew, Anurag Mehta. The Global Epidemic of Metabolic Fatty Liver Disease. Current Cardiology Reports 2024; 26(4): 199 doi: 10.1007/s11886-024-02025-6
79
Ramasamy Selvarani, HoangVan Michelle Nguyen, Natesan Pazhanivel, Muthusamy Raman, Sunho Lee, Roman F. Wolf, Sathyaseelan S. Deepa, Arlan Richardson. The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet. GeroScience 2024;  doi: 10.1007/s11357-024-01418-3
80
Gaoxuan Shao, Ying Liu, Lu Lu, Guangtao Zhang, Wenjun Zhou, Tao Wu, Lei Wang, Hanchen Xu, Guang Ji. The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.944088
81
Mariana Verdelho Machado. Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance. GE - Portuguese Journal of Gastroenterology 2017; 24(4): 157 doi: 10.1159/000478944
82
Vikas Gupta, Xian-Jun Mah, Maria Carmela Garcia, Christina Antonypillai, David van der Poorten. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(37): 10621-10635 doi: 10.3748/wjg.v21.i37.10621
83
Mi Kyung Shin, Soo-Man Yang, In-Seob Han. Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. Animal Cells and Systems 2020; 24(4): 214 doi: 10.1080/19768354.2020.1810771
84
Jorge Fonseca, Gonçalo Nunes, Cristina Fonseca, Manuela Canhoto, Ana Teresa Barata, Carla Adriana Santos. Comment to: “EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease”. Journal of Hepatology 2017; 66(2): 465 doi: 10.1016/j.jhep.2016.10.036
85
ShuTing Wu, XinXin Wang, WenBo Xing, FenYao Li, Ming Liang, KeShen Li, Yan He, JianMing Wang. An update on animal models of liver fibrosis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1160053
86
Tessa Kennedy-Martin, Jay P. Bae, Rosirene Paczkowski, Emily Freeman. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review. Journal of Patient-Reported Outcomes 2018; 2(1) doi: 10.1186/s41687-018-0052-7
87
Yetong Feng, Mengjiao Shi, Yi Zhang, Xinyan Li, Liangwen Yan, Jiayi Xu, Chenyue Liu, Miaomiao Li, Fengyun Bai, Fenyue Yuan, Ying Sun, Rongrong Liu, Yaping Zhao, Lan Yang, Yinggang Zhang, Ying Guo, Jian Zhang, Rui Zhou, Pengfei Liu. Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway. Cell Biology and Toxicology 2024; 40(1) doi: 10.1007/s10565-024-09953-7
88
Evi Bakiris, Kaisu Luiro, Jari Jokelainen, Laure Morin‐Papunen, Sirkka Keinänen‐Kiukaanniemi, Kari Kaikkonen, Terhi Piltonen, Juha S. Tapanainen, Juha Auvinen. Women with a history of gestational diabetes mellitus present an accumulation of cardiovascular risk factors at age 46—A birth cohort study. Acta Obstetricia et Gynecologica Scandinavica 2024; 103(7): 1318 doi: 10.1111/aogs.14861
89
慧鑫 袁. Historical Evolution of Spleen. Traditional Chinese Medicine 2018; 7(06): 381 doi: 10.12677/TCM.2018.76064
90
Helena Cortez-Pinto, Paula Borralho, Jorge Machado, Maria T. Lopes, Inês V. Gato, António M. Santos, António S. Guerreiro. Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH). GE Portuguese Journal of Gastroenterology 2016; 23(3): 132 doi: 10.1016/j.jpge.2016.01.004
91
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6554
92
Arne Janssen, Diederick E Grobbee, Paul Dendale. Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease. European Journal of Preventive Cardiology 2020; 27(10): 1059 doi: 10.1177/2047487319891783
93
Ahmed Mohamed Kamel, Mohamed Ali Farag. Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis. Journal of Medicinal Food 2022;  doi: 10.1089/jmf.2022.0025
94
Ângela Fernandes, Ana M. Dias, Mariana C. Silva, Joana Gaifem, Catarina M. Azevedo, Iago Carballo, Salomé S. Pinho. Comprehensive Glycoscience. 2021; : 444 doi: 10.1016/B978-0-12-819475-1.00036-5
95
Hikmet Akkiz, Emre Taskin, Umit Karaogullarindan, Anil Delik, Sedef Kuran, Ozlem Kutlu. The influence of RS738409 I148M polymorphism of patatin-like phospholipase domain containing 3 gene on the susceptibility of non-alcoholic fatty liver disease. Medicine 2021; 100(19): e25893 doi: 10.1097/MD.0000000000025893
96
Rolf K. Berge, Bodil Bjørndal, Elin Strand, Pavol Bohov, Carine Lindquist, Jan Erik Nordrehaug, Asbjørn Svardal, Jon Skorve, Ottar Nygård. Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0192-9
97
Juan Caballeria, Llorenç Caballeria. Non-alcoholic fatty liver disease. Role of primary care physicians. Medicina Clínica (English Edition) 2015; 145(3): 112 doi: 10.1016/j.medcle.2016.01.002
98
Jiaorong Tan, Jiahong Xu, Guohua Wei, Lijuan Zhang, Long’e Sun, Guangyu Wang, Fei Li, Fengxiang Jiang. HNF1α Controls Liver Lipid Metabolism and Insulin Resistance via Negatively Regulating the SOCS-3-STAT3 Signaling Pathway. Journal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/5483946
99
Li-Jing Qin, Zhang Lu, Zhong-Hua Zheng, Xiu-Hong Zhong. Research progress of natural products interfering with cell signaling pathway in liver fibrosis. Journal of Asian Natural Products Research 2022; 24(1): 15 doi: 10.1080/10286020.2021.1883003
100
Hyunsoo Jang, Hyunchae Joung, Jaeryang Chu, Minseo Cho, Yeon-Woo Kim, Kyung Hwan Kim, Chang Hun Shin, Jisu Lee, Jung-Heun Ha. Lactobacillus delbrueckii subsp. lactis CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice. Nutrients 2024; 16(24): 4260 doi: 10.3390/nu16244260
101
Lynda Aoudjehane, Jérémie Gautheron, Wilfried Le Goff, Claire Goumard, Julia Gilaizeau, Chan Sonavine Nget, Eric Savier, Muhammad Atif, Philippe Lesnik, Romain Morichon, Yves Chrétien, Yvon Calmus, Olivier Scatton, Chantal Housset, Filomena Conti. Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis. Disease Models & Mechanisms 2020;  doi: 10.1242/dmm.042663
102
Cheng Wang, Junbin Yan, Shuo Zhang, Yiwen Xie, Yunmeng Nie, Zhiyun Chen, Sumei Xu. Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.771219
103
Daniela Gabbia, Marco Roverso, Ilaria Zanotto, Martina Colognesi, Katia Sayaf, Samantha Sarcognato, Diletta Arcidiacono, Alice Zaramella, Stefano Realdon, Nicola Ferri, Maria Guido, Francesco Paolo Russo, Sara Bogialli, Maria Carrara, Sara De Martin. A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH. Marine Drugs 2022; 20(9): 572 doi: 10.3390/md20090572
104
Uijin Kim, Nahyun Kim, Ha Youn Shin. Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing Tools. Cells 2020; 9(12): 2572 doi: 10.3390/cells9122572
105
Rania Elsyade, Eman El Sawaf, Dalia Gaber. Hazards of Chronic Exposure to Nonylphenol: Concomitant Effect on Non-alcoholic Fatty Liver Disease in Male Albino Rats. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 548 doi: 10.3889/oamjms.2021.6237
106
Zhaolin Sun, Yuhua Wei, Yuchen Xu, Jianwei Jiao, Xiuying Duan. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review. Pharmacological Research - Modern Chinese Medicine 2024; 12: 100475 doi: 10.1016/j.prmcm.2024.100475
107
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
108
Llorenç Caballería Rovira, Irfan Majeed, Alba Martínez Escudé, Ingrid Arteaga Pillasagua, Pere Torán Monserrat. Esteatosis hepática: diagnóstico y seguimiento. FMC - Formación Médica Continuada en Atención Primaria 2017; 24(7): 378 doi: 10.1016/j.fmc.2017.03.001
109
Jin-ming Zhang, Xing-he Wang, Li-hong Hao, He Wang, Xiu-ying Zhang, Ishfaq Muhammad, Yue Qi, Guang-liang Li, Xiao-qi Sun. Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cells. Environmental Toxicology and Pharmacology 2017; 52: 21 doi: 10.1016/j.etap.2017.03.003
110
FX Himawan Haryanto Jong, Ari Gunawan, Mochamad Wirono Aman Santoso, Susilowati Anjani, Ni Wayan Tirthaningsih, Ahmad Basori. Effects of Sambiloto Ethanol Extract on Fatty Liver, SGOT/SGPT Levels and Lipid Profile of Wistar Strain White Rat (Rattus norvegicus) Exposed to High-Fat Diet. Folia Medica Indonesiana 2018; 54(2): 89 doi: 10.20473/fmi.v54i2.8856
111
Mahyar Mohammadifard, Masood Ziaee, Gholamreza Sharifzadeh, Toba Kazemi, Zohreh Azarkar, Mahboubeh Saljoughi, Azadeh Ebrahimzadeh. Evaluation of Liver Enzyme Elevation and Its Contributing Factors in Birjand, Iran. Modern Care Journal 2017; 14(4) doi: 10.5812/modernc.68238
112
Patrick H. Sweet, Teresa Khoo, Steven Nguyen. Nonalcoholic Fatty Liver Disease. Primary Care: Clinics in Office Practice 2017; 44(4): 599 doi: 10.1016/j.pop.2017.07.003
113
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. Clínica e Investigación en Arteriosclerosis (English Edition) 2021; 33(5): 257 doi: 10.1016/j.artere.2021.09.001
114
da Silva Robin P, Eudy Brandon J, Deminice Rafael. One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them All. The Journal of Nutrition 2020; 150(5): 994 doi: 10.1093/jn/nxaa032
115
Jovanna Tsoutsouki, Ali Abbara, Waljit Dhillo. Novel therapeutic avenues for kisspeptin. Current Opinion in Pharmacology 2022; 67: 102319 doi: 10.1016/j.coph.2022.102319
116
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
117
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24): 15489 doi: 10.3390/ijms232415489
118
Elina G. Manzhalii, Valentyna O. Moyseyenko, Tetyana M. Falalyeyeva, Olena I. Tsyryuk, Vitaliy E. Kondratiuk, Taras D. Nykula. Increasing efficacy of treatment in patients with steatohepatitis and concomitant chronic colitis. Current Issues in Pharmacy and Medical Sciences 2019; 32(1): 23 doi: 10.2478/cipms-2019-0005
119
Mehonaz Sultana, Md Asrarul Islam, Rhema Khairnar, Sunil Kumar. A guide to pathophysiology, signaling pathways, and preclinical models of liver fibrosis. Molecular and Cellular Endocrinology 2025; 598: 112448 doi: 10.1016/j.mce.2024.112448
120
Yixin Niu, Weiwei Zhang, Zhen Yang, Xiaoyong Li, Wenjun Fang, Hongmei Zhang, Suijun Wang, Houguang Zhou, Jiangao Fan, Li Qin, Qing Su. Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case–control study in China. Metabolism 2016; 65(4): 475 doi: 10.1016/j.metabol.2015.12.005
121
M. Hites, F. S. Taccone. Optimization of antibiotic therapy in the obese, critically ill patient. Réanimation 2015; 24(3): 278 doi: 10.1007/s13546-015-1060-8
122
Michael S. Middleton, Elhamy R. Heba, Catherine A. Hooker, Mustafa R. Bashir, Kathryn J. Fowler, Kumar Sandrasegaran, Elizabeth M. Brunt, David E. Kleiner, Edward Doo, Mark L. Van Natta, Joel E. Lavine, Brent A. Neuschwander-Tetri, Arun Sanyal, Rohit Loomba, Claude B. Sirlin. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. Gastroenterology 2017; 153(3): 753 doi: 10.1053/j.gastro.2017.06.005
123
Umar Hayat, Ali A. Siddiqui, Muhammad L. Farhan, Ahmed Haris, Nasir Hameed. Genome Editing in Cardiovascular and Metabolic Diseases. Advances in Experimental Medicine and Biology 2023; 1396: 191 doi: 10.1007/978-981-19-5642-3_13
124
Rolf K. Berge, Daniel Cacabelos, Rosa Señarís, Jan Erik Nordrehaug, Ottar Nygård, Jon Skorve, Bodil Bjørndal. Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD+/NADH ratio. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01271-1
125
Fengfeng Li, Man Jiang, Minghui Ma, Xuyang Chen, Yidan Zhang, Yixin Zhang, Yuanyuan Yu, Yunfeng Cui, Jiahui Chen, Hui Zhao, Zhijie Sun, Deli Dong. Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice. Acta Pharmaceutica Sinica B 2022; 12(3): 1322 doi: 10.1016/j.apsb.2021.09.009
126
Yafang Yang, Ligang Yang, Jiale Wu, Jing Hu, Min Wan, Jindi Bie, Jiaxin Li, Da Pan, Guiju Sun, Chao Yang. Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis. Clinical Nutrition 2024; 43(6): 1224 doi: 10.1016/j.clnu.2024.04.004
127
Tanvi Singla, Komal N Muneshwar, Aniket G Pathade, Seema Yelne. Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues. Cureus 2023;  doi: 10.7759/cureus.45884
128
Maria J. Guillen-Sacoto, Ariel F. Martinez, Yu Abe, Paul Kruszka, Karin Weiss, Joshua L. Everson, Ramon Bataller, David E. Kleiner, Jerrold M. Ward, Kathleen K. Sulik, Robert J. Lipinski, Benjamin D. Solomon, Maximilian Muenke. Human germline hedgehog pathway mutations predispose to fatty liver. Journal of Hepatology 2017; 67(4): 809 doi: 10.1016/j.jhep.2017.06.008
129
Ping Ye, Jijun Liu, Wuping Xu, Denghai Liu, Xiangchao Ding, Sheng Le, Hao Zhang, Shanshan Chen, Manhua Chen, Jiahong Xia. Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 Suppression. Hepatology 2019; 69(5): 1946 doi: 10.1002/hep.30485
130
Krzysztof Drygalski, Katarzyna Siewko, Andrzej Chomentowski, Cezary Odrzygóźdź, Anna Zalewska, Adam Krętowski, Mateusz Maciejczyk, Ayman Mahmoud. Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD). Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/8872702
131
Mehmet Yilmaz, Oner Odabas, Mustafa Karaaslan, Omer Faruk Guler, Tuncay Toprak, Sait Bicer, Senol Tonyali. Predicting risk of erectile dysfunction in patients with nonalcoholic fatty liver disease. Andrologia 2021; 53(7) doi: 10.1111/and.14091
132
Abdul Sattar Arif Khammas, Hasyma Abu Hassan, Sarah Qahtan M. Salih, Hayati Kadir, Ramlah Mohamad Ibrahim, Nurul Nadiah Mohamad Nasir, Rozi Mahmud. Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. Porto Biomedical Journal 2019; 4(2): e31 doi: 10.1016/j.pbj.0000000000000031
133
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
134
Lampros Chrysavgis, Alkistis‐Maria Papatheodoridi, Antonios Chatzigeorgiou, Evangelos Cholongitas. The impact of sodium glucose co‐transporter 2 inhibitors on non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2021; 36(4): 893 doi: 10.1111/jgh.15202
135
Tahmine Tavakoli, Asghar Zarban, Reyhaneh Hooshyar, Fatemeh Salmani, Hamidreza Tajik. Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone. Archives of Physiology and Biochemistry 2022; 128(6): 1591 doi: 10.1080/13813455.2020.1784953
136
Moushira Zaki, Darine Amin, Ramy Mohamed. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease. Journal of Complementary and Integrative Medicine 2021; 18(2): 385 doi: 10.1515/jcim-2020-0073
137
Pengcheng Chen, Ze Yang, Lingyun Guo, Yingfei Huang, Jingjia Li, Xin Chen. Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1083855
138
Meiying Yan, Jingxuan Wang, Qijia Xuan, Tieying Dong, Juan He, Qingyuan Zhang. The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer. Clinical Breast Cancer 2017; 17(3): 195 doi: 10.1016/j.clbc.2016.12.004
139
Rasika Pradeep Herath, Shirom R. Siriwardana, Chanil D. Ekanayake, Vikum Abeysekara, Sajith U. A. Kodithuwakku, Himali P. Herath, Jonathan M. Peterson. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. PLOS ONE 2019; 14(4): e0215326 doi: 10.1371/journal.pone.0215326
140
Erin Nicole Young, Murat Dogan, Christine Watkins, Amandeep Bajwa, James D. Eason, Canan Kuscu, Cem Kuscu. A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(19): 11805 doi: 10.3390/ijms231911805
141
Roni Lehmann-Werman, Judith Magenheim, Joshua Moss, Daniel Neiman, Ofri Abraham, Sheina Piyanzin, Hai Zemmour, Ilana Fox, Talya Dor, Markus Grompe, Giora Landesberg, Bao-Li Loza, Abraham Shaked, Kim Olthoff, Benjamin Glaser, Ruth Shemer, Yuval Dor. Monitoring liver damage using hepatocyte-specific methylation markers in cell-free circulating DNA. JCI Insight 2018; 3(12) doi: 10.1172/jci.insight.120687
142
Na Li, Ying Liu, Shujun Yu, Bin Hu, Hui Zhao. Composite BMI and Waist-to-Height Ratio Index for Risk Assessment of Non-alcoholic Fatty Liver Disease in Adult Populations. Hepatitis Monthly 2021; 20(12) doi: 10.5812/hepatmon.103607
143
Manar A. Serageldin, Amira B. Kassem, Yasser El-Kerm, Maged W. Helmy, Mahmoud M. El-Mas, Noha A. El-Bassiouny. The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study. Drug Safety 2023; 46(6): 587 doi: 10.1007/s40264-023-01305-4
144
Tian Lan, Bo Chen, Xianzhe Hu, Jiafan Cao, Shiyun Chen, Xin Ding, Shengwen Li, Yanfang Fu, Huanle Liu, Duosheng Luo, Xianglu Rong, Jiao Guo. Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway. Journal of Ethnopharmacology 2024; 321: 117516 doi: 10.1016/j.jep.2023.117516
145
Iria Cebreiros López, Florentina Guzmán Aroca, Maria Dolores Frutos Bernal, Juan Antonio Luján Mompeán, Águeda Bas Bernal, Antonio Miguel Hernández Martínez, Enrique Martínez Barba, Jose Antonio Noguera Velasco, Pascual Parilla Paricio. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease. Obesity Surgery 2017; 27(9): 2347 doi: 10.1007/s11695-017-2606-9
146
Gholampour Firouzeh, Abbasi Susan, Karimi Zeinab. Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression. Current Research in Pharmacology and Drug Discovery 2024; 7: 100201 doi: 10.1016/j.crphar.2024.100201
147
Muhammad Nadeem Yousaf, Fizah S Chaudhary, Wajahat Z Mehal. The impact of scoring system in the evaluation of Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Gastroenterology & Hepatology: Open Access 2019; 10(5): 262 doi: 10.15406/ghoa.2019.10.00392
148
Mariana Verdelho Machado, Anna Diehl. Role of Hedgehog Signaling Pathway in NASH. International Journal of Molecular Sciences 2016; 17(6): 857 doi: 10.3390/ijms17060857
149
Ammar Salehi-sahlabadi, Samaneh Sadat, Sara Beigrezaei, Makan Pourmasomi, Awat Feizi, Reza Ghiasvand, Amir Hadi, Cain C. T. Clark, Maryam Miraghajani. Dietary patterns and risk of non-alcoholic fatty liver disease. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01612-z
150
Lia Silveira Adriano, Helena Alves de Carvalho Sampaio, Soraia Pinheiro Machado Arruda, Clarissa Lima de Melo Portela, Maria Luisa Pereira de Melo, Antônio Augusto Ferreira Carioca, Nadia Tavares Soares. Healthy dietary pattern is inversely associated with non-alcoholic fatty liver disease in elderly. British Journal of Nutrition 2016; 115(12): 2189 doi: 10.1017/S0007114516001410
151
Mingzuo Jiang, Nan Wu, Xi Chen, Weijie Wang, Yi Chu, Hao Liu, Wenjiao Li, Di Chen, Xiaowei Li, Bing Xu. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. Journal of International Medical Research 2019; 47(4): 1453 doi: 10.1177/0300060519833527
152
Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial. Clinical and Experimental Pediatrics 2022; 65(6): 304 doi: 10.3345/cep.2021.00787
153
A. Mancuso. Letter: why treatments of hepatitis C virus are less effective in cirrhosis. Alimentary Pharmacology & Therapeutics 2015; 41(7): 707 doi: 10.1111/apt.13118
154
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sciences 2021; 270: 119071 doi: 10.1016/j.lfs.2021.119071
155
Tracy Bonsu Osei, Anne-Marieke van Dijk, Sjoerd Dingerink, Felix Patience Chilunga, Erik Beune, Karlijn Anna Catharina Meeks, Silver Bahendeka, Matthias Bernd Schulze, Charles Agyemang, Mary Nicolaou, Adriaan Georgius Holleboom, Ina Danquah. Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study. Nutrients 2021; 13(11): 3679 doi: 10.3390/nu13113679
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345